Hosted by the European Commission, this hybrid event takes stock of the implementation of the EU health technology assessment regulation half-way into its first year of application. The conference also seeks to explore the broader implications of the regulation on EU member states and the global HTA landscape.
Online/Brussels
Ask for a Free trial and get access to the latest stories
Our coverage includes:
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
REQUEST
an initial 10 day temporary access of APM Market Access.
